You're sourcing TB-500 for a research protocol. The vendor shows you a Janoshik COA: 98.6% purity. Looks legitimate. You order.

What you don't realize: That COA is from February. It's now June. The vial they're shipping you is from a completely different batch that was never tested.

You might be getting 98.6% purity. Or 94%. Or 91%. Who knows? Nobody tested YOUR batch.

This isn't a scam. It's just how most vendors operate. And it's a massive problem nobody talks about.

The "One COA Forever" Trick

Here's how it works:

  1. Vendor receives 100 vials of TB-500 from their supplier
  2. They send ONE vial to Janoshik for testing
  3. It comes back at 98.2% purity. Great!
  4. They post that COA on their website
  5. They sell all 100 vials using that one COA
  6. Three months later, they get another 100 vials from a different production batch
  7. They sell those too... using the SAME COA from February
  8. Rinse, repeat

One test. Hundreds of vials. Multiple batches. Zero accountability.

This practice—testing one batch but applying results to many—is common enough that it's worth understanding the gap between what a COA shows and what you actually receive.

Why This Matters More Than You Think

Peptide synthesis isn't like stamping out widgets. Every batch is different.

Maybe the supplier switched raw material vendors. Maybe they adjusted the temperature during synthesis. Maybe it sat in a warehouse for an extra month before shipping. Maybe it went through customs in 110°F heat.

All of that affects purity. And you'd never know.

Consider four consecutive batches of the same peptide:

All could be sold as "98.5% pure" if the vendor only tested Batch 1 and applied that COA to subsequent batches.

If you ordered in March and got Batch 3, you're working with peptide that's 5.7% less pure than advertised. Your dose-response curves are going to be off. Your replication attempts will fail. You'll blame your technique when it was the peptide all along.

The Part Where I Show You Math

Testing every batch costs money. Let's break down why vendors don't do it:

Janoshik testing for BPC-157:

Testing every batch means:

For a vendor selling BPC-157 at $35/vial with small batch sizes, that testing cost can exceed the product cost itself. That's why most vendors don't do it.

Their approach instead:

Way better margins. Way worse quality control.

How to Spot Product-Line Testing

Here are the red flags:

The COA has no batch number: If it just says "Sample: TB-500 10mg" with no batch identifier, that's product-line testing. It's not verifying a specific batch.

The test date doesn't match the batch you received: You order in June and receive Batch 045. The posted COA is dated January for Batch 038. The test date itself isn't the issue—properly stored lyophilized peptides are stable for 12-24 months. The issue is batch mismatch: the COA doesn't verify your material.

No batch number on your vial: If the vial label doesn't indicate which batch it's from, batch tracking isn't happening.

Same COA for months: If the posted COA hasn't changed in 4+ months while they're actively selling, they're applying one test to multiple batches.

"We test every product": "Every product" ≠ "every batch." Testing TB-500 once but selling 200 vials from 20 different batches means 19 batches were never tested.

The Vendor's Defense (And Why It's BS)

"Our supplier is consistent!"

Synthesis variability exists even with well-controlled suppliers. Pharmaceutical manufacturers test every batch even when using the same supplier for years because GMP regulations require batch release testing—not because suppliers are untrustworthy, but because process variation is inherent to peptide synthesis.

"Testing is too expensive!"

Testing adds $25-40 per vial in overhead for small-batch vendors. That cost gets built into pricing. Vendors offering significantly below-market pricing typically aren't testing every batch—they're amortizing one test across hundreds or thousands of vials.

"Customers don't care!"

Some don't. Some do. If you're trying to publish reproducible research, you should care. If you're running a six-month study, you should care. If you don't care... well, you'll figure it out when your experiments don't replicate.

What Actually Batch-Specific Testing Looks Like

Here's the Vantix system (and what you should demand from any vendor):

When a shipment arrives (say, 12 vials of TB-500), we assign a batch identifier and place all vials on hold. One vial ships to Janoshik for HPLC purity, LC-MS identification, and endotoxin testing ($360). Results take 5-7 days.

The COA comes back. We verify purity >99%, peptide content ≥95%, and endotoxin ≤1.0 EU/mg. If the batch passes, we label vials with the batch ID and add QR codes linking to that batch's COA. If it fails, the entire batch is rejected.

When you order, your vial label shows the batch ID. Scan the QR code and you see the exact Janoshik PDF for that batch—not a generic product COA, but the actual test results for the material in your hand.

The Questions You Should Ask

Before you buy from ANYONE (including us), ask these:

1. "What batch number will I receive?"

If they can't tell you, they're not tracking batches.

2. "Can I see the COA for that specific batch?"

If they send you a COA with no batch number or a different batch number than what they said you'll receive, that's product-line testing.

3. "When was this batch tested?"

If it's more than 2-3 months old and they're still selling from it, either they have terrible turnover (bad sign) or they're selling multiple batches under one COA (worse sign).

4. "Do you reject batches that don't meet spec?"

If they say "our supplier never sends bad batches," they're either lying or not testing enough to know. Every supplier has bad batches sometimes. The question is whether they catch them.

Why This Matters for Your Research

Let's say you're running a 12-week study. You order peptide in Week 1. You order again in Week 7 because you're running low.

Without batch tracking:

With batch tracking:

Batch-specific testing turns a black box into a controlled variable.

The Cost Reality

Yes, batch testing makes peptides more expensive. Here's the honest breakdown:

Budget vendor selling TB-500 10mg:

Batch-testing vendor selling TB-500 10mg:

Lower margins, higher testing costs. The price difference reflects verification overhead, not markup.

What We'd Do Better If We Could

Batch-specific testing is good. But it's not perfect. Here's what would make it even better:

Test every vial (not every batch): Pharmaceutical manufacturers test final-release samples from every batch, but not every individual vial. Full per-vial testing at $360/unit would make research peptides economically unviable.

Longitudinal degradation monitoring: Re-testing stored batches every 30-60 days would provide real-world stability data. Expensive, but would meaningfully advance understanding of peptide shelf life under actual storage conditions.

Cryptographic verification: Blockchain or cryptographically signed COAs would prevent backdating or alteration. Technically feasible, not yet standard practice.

Batch-specific testing with third-party verification remains the practical standard for research-grade material.

The Bottom Line

Many COAs in the research peptide industry represent product-line testing rather than batch-specific verification. They provide general quality indicators but don't verify the specific material you received.

If you care about reproducible research, demand:

  1. Batch numbers on every vial
  2. Batch-specific COAs (not product-line)
  3. Test dates that reconcile with the batch's production date (not a generic product COA reused across runs)
  4. Verifiable QR codes or URLs linking to the actual test results

If a vendor can't provide that, you're gambling on quality. Sometimes you'll win. Sometimes you won't. But you won't know until you've already wasted time and money.

The choice is between lower cost with assumed quality or higher cost with verified quality. Neither is wrong—they serve different research needs.

Batch-Specific Verification

Janoshik HPLC + LC-MS + endotoxin testing on every batch. QR-linked COAs on every vial.

View Catalog

Research Use Only. These peptides are for laboratory research only. Not for human consumption. Not medical advice.